Today, the Government of Alberta passed amendments to the Scheduled Drugs Regulation designating “Naloxone and its salts for use in emergency treatment of opioid overdose outside of hospital” as a Schedule 2 product (available without a prescription). This change takes effect as of May 13, 2016. This amendment is one more step to help address the rising number of opioid (including fentanyl) overdoses and deaths by increasing access to take-home naloxone (THN) kits for at-risk Albertans.
To support our professions, ACP is providing pharmacists and pharmacy technicians with guidance to comply with ACP’s Code of Ethics and Standards of Practice for dispensing or selling Naloxone as a Schedule 2 drug. The guidance document can be accessed here: Guidance for Pharmacists and Pharmacy Technicians – Dispensing or Selling Naloxone
